Identifying Global Drivers of Cancer Survival
MSK AI Models Bolster Patient Safety and Cancer Tracking
New AI systems automate hospital incident reviews and identify global drivers of cancer survival disparities.

A high-tech hospital data center showing global health maps and medical analytics on large digital screens, representing the use of AI in oncology and patient safety.
Photo: Avantgarde News
Memorial Sloan Kettering (MSK) researchers have developed a new artificial intelligence system, known as AI-ILS, to automate the review of medical incidents and "near-misses" [1][3]. The model utilizes the Human Factors Analysis and Classification System (HFACS) to identify safety threats and classify incident causes with 88% expert concordance [3]. Operating 29 times faster than traditional human review, the tool allows clinical teams to focus on designing safer workflows rather than administrative tasks [1][3]. In a parallel international study, MSK scientists deployed a machine-learning framework to analyze cancer survival disparities across 185 countries [1][2]. The AI-driven analysis identified three paramount drivers influencing national outcomes: economic strength, the availability of radiotherapy infrastructure, and the presence of universal health coverage [2]. By mapping these factors, the tool provides actionable roadmaps for policymakers to prioritize health system investments and close equity gaps [1][2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View allTopics
About the author
Avantgarde News Desk covers identifying global drivers of cancer survival and editorial analysis for Avantgarde News.


